Research Article: Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer
Introduction:
Pancreatic cancer (PC) is one of the major causes of cancer deaths. Between % and % of patients are diagnosed in a too advanced stage, which prevents the tumor resection. Even so, when resection occurs, the survival rate of patients is usually relatively low (about % at years). Also, there is an absence of effective chemotherapeutic agents when the tumor is irresectable. Among them, Gemcitabine has been the agent of choice since the s, but better response rates have been observed using FOLFIRINOX, a combination of…
Read more